Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Jul 25, 2021 8:10pm
134 Views
Post# 33602540

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Additional thoughts on the ATM

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Additional thoughts on the ATM

How often did you say trust the company or sell, well that's a great sale pitch to new investors! The trust has to be earned, opacity isn't going to cut it I am afraid. Yes there is constant need for clear communication so investors understand why they should invest in this company and stay invested rather than go with hundreds of similar other small caps. To announce the ATM program and not stating what those $50M are going to be used for to me just doesn't make this company more investable or trustworthy. They said they have learned from previous mistakes and have a plan going forward I really want to see signs that all that wasn't only empty promises. We need to see the cause before the effect. Some might be happy to get diluted not knowing why, not me...




jfm1330 wrote: Always this communication cr*p over and over. I think one reason I would want really great news in oncology is that it will show how fast the news will spread without anything different made by the management.

 

Scioto1 wrote:
I agree scarlet. Not 5 months after a financial move without sound communication to shareholders, and all the turmoil that created, we get this release, end of the week with with no meaningful communication.




<< Previous
Bullboard Posts
Next >>